What Is the Best Medication for Endometriosis?

Ask five people with endometriosis which medication works best, and you may receive five different answersplus one passionate speech about heating pads. That is because there is no single “best medication for endometriosis” for everyone. The right choice depends on the type of pain, bleeding pattern, medical history, side-effect tolerance, contraceptive needs, and whether pregnancy is a current goal.

For many people who are not trying to become pregnant, the usual first choices are continuous combined hormonal birth control or a progestin-only medication. A nonsteroidal anti-inflammatory drug, or NSAID, may be added for pain relief. If these options do not work, a gynecologist may recommend a gonadotropin-releasing hormone medication, commonly called a GnRH agonist or antagonist.

Medication can reduce pain, limit menstrual bleeding, and suppress the hormonal stimulation of endometriosis. However, it does not reliably eliminate existing lesions, adhesions, or scar tissue. Endometriosis is a chronic condition, so treatment is generally about controlling symptoms, protecting quality of life, and coordinating care with fertility goalsnot finding a magical tablet that evicts every lesion by Friday afternoon.

The Quick Answer: Which Medication Is Usually Best?

For a patient with suspected or confirmed endometriosis who is not currently trying to conceive, clinicians commonly start with one of the following:

• Combined hormonal contraception, such as a pill, patch, or vaginal ring, often used continuously to reduce or stop periods.
• Progestin-only therapy, such as norethindrone acetate, medroxyprogesterone, a progestin implant, an injection, or a levonorgestrel-releasing intrauterine device.
• An NSAID, such as ibuprofen or naproxen, for short-term relief of menstrual cramps and inflammatory pain.

Combined hormonal contraception and progestin-only treatment are both widely used as first-line hormonal therapies. Progestin-only treatment may be preferable when estrogen is unsafe, poorly tolerated, or simply not invited to the party.

If pain remains moderate to severe despite first-line treatment, prescription options such as elagolix, relugolix combination therapy, or leuprolide may be considered. These medications can be effective, but their potential effects on bones, mood, cholesterol, hot flashes, and pregnancy require closer medical supervision.

Why Hormonal Medication Helps Endometriosis

Endometriosis is an estrogen-responsive inflammatory disease. Tissue similar to the uterine lining grows outside the uterus, most commonly in the pelvis. These lesions may contribute to painful periods, chronic pelvic pain, pain during sex, bowel or bladder symptoms, fatigue, and infertility. The amount of visible disease does not always match the severity of pain; a person with relatively small lesions may experience major symptoms.

Hormonal medication changes or suppresses the menstrual cycle. Depending on the drug, it may prevent ovulation, reduce estrogen activity, thin hormonally responsive tissue, or stop menstrual bleeding. Fewer cycles generally mean less repeated hormonal stimulation and, for many patients, less pain.

Symptoms can return after treatment stops. That does not necessarily mean the medication failed; it may mean the medication was successfully suppressing a chronic disease while it was being used.

First-Line Medications for Endometriosis

1. NSAIDs for Endometriosis Pain

NSAIDs include ibuprofen and naproxen. These medicines reduce the production of prostaglandins, chemicals involved in inflammation and menstrual cramping. They may be especially useful when taken according to a clinician’s instructions shortly before an expected period or when symptoms begin.

NSAIDs can ease pain, but they do not suppress ovulation or directly treat hormonally responsive lesions. They are often combined with hormonal therapy rather than used as the entire long-term strategy. Acetaminophen may also help some patients, although it works differently and does not have the same anti-inflammatory action.

More is not always better. Excessive NSAID use can contribute to stomach irritation, ulcers, bleeding, kidney problems, and other complications. People with kidney disease, gastrointestinal bleeding, cardiovascular conditions, anticoagulant use, or pregnancy should discuss pain-reliever choices with a healthcare professional.

2. Combined Hormonal Birth Control

Combined hormonal contraception contains estrogen and a progestin. It is available as oral pills, skin patches, and vaginal rings. For endometriosis, clinicians frequently recommend continuous use, meaning the hormone-free week is reduced or skipped to limit menstrual bleeding.

This option may be a practical first choice because it can address painful periods, heavy or irregular bleeding, and contraceptive needs at the same time. It is also familiar, reversible, and generally less expensive than newer specialty medications.

Possible side effects include spotting, nausea, breast tenderness, headaches, and mood changes. Estrogen-containing medication may not be appropriate for people with certain blood-clot risks, uncontrolled hypertension, migraine with aura, particular cardiovascular conditions, or other contraindications. The safest choice depends on the individual’s complete historynot on whichever pill a friend enthusiastically recommends during brunch.

3. Progestin-Only Medication

Progestins counter estrogen-driven growth and can thin hormonally responsive tissue. Common options include oral norethindrone acetate, medroxyprogesterone tablets or injections, the etonogestrel implant, and levonorgestrel-releasing intrauterine devices.

A progestin-only medication may be one of the best endometriosis treatments for someone who:

• Cannot safely use estrogen.
• Experiences migraines or nausea with combined birth control.
• Needs long-term contraception.
• Wants fewer periods or no periods.
• Prefers an implant, injection, or intrauterine device over a daily pill.

Irregular bleeding is common, especially during the first few months. Other possible effects include acne, bloating, breast tenderness, headaches, appetite changes, or mood symptoms. An injection may take longer to wear off than a pill, while an intrauterine device requires placement but needs little daily attention afterward.

Prescription Options for Moderate to Severe Pain

Elagolix: An Oral GnRH Antagonist

Elagolix, sold under the brand name Orilissa, is FDA-approved for moderate to severe pain associated with endometriosis. It lowers ovarian hormone production by blocking GnRH receptors. Unlike older GnRH agonists, it does not initially trigger the same temporary hormone surge or “flare.”

Elagolix can improve painful periods, nonmenstrual pelvic pain, and, at certain dosing levels, pain during sex. Treatment duration is limited because bone mineral density may decline in a dose- and duration-dependent manner and may not fully recover after discontinuation.

Other potential effects include hot flashes, night sweats, headaches, nausea, sleep problems, vaginal dryness, mood changes, and changes in cholesterol. It is contraindicated during pregnancy and in patients with known osteoporosis or certain liver conditions. Because menstrual bleeding may decrease, pregnancy can be harder to recognize, making pregnancy testing and appropriate contraception important.

Relugolix, Estradiol, and Norethindrone Acetate

Myfembree combines the GnRH antagonist relugolix with low-dose estradiol and norethindrone acetate. It is FDA-approved for moderate to severe endometriosis pain in premenopausal women. The added hormones are intended to reduce some effects of low estrogen, including hot flashes and bone loss, while protecting the uterine lining.

Use is limited to 24 months because continued bone loss may not be reversible. The medication carries a boxed warning concerning thrombotic and thromboembolic disorders. It is not suitable for everyone, including certain patients with clotting risks, uncontrolled hypertension, osteoporosis, liver disease, hormone-sensitive cancers, or pregnancy.

GnRH Agonists Such as Leuprolide

Leuprolide, commonly known by the brand Lupron Depot, is an injectable GnRH agonist. After a brief initial hormone stimulation, it substantially reduces ovarian estrogen production. It can relieve endometriosis pain and reduce lesion activity, but it may also cause menopause-like effects.

Hot flashes, vaginal dryness, headaches, mood changes, and bone mineral density loss are important considerations. Clinicians frequently use “add-back therapy,” often involving norethindrone acetate, to reduce vasomotor symptoms and protect bone health without eliminating the treatment’s benefit.

The FDA labeling limits the total duration of leuprolide plus add-back therapy for endometriosis because of bone-density concerns. Bone-health history, previous treatment, and possible retreatment must be assessed carefully.

Medications Used Less Frequently

Danazol

Danazol suppresses ovarian hormone production and can reduce endometriosis pain. However, it is rarely a preferred modern treatment because androgenic side effects may include acne, oily skin, facial or body-hair growth, voice changes, weight gain, and unfavorable cholesterol changes.

It can harm a developing fetus and may interfere with hormonal contraception. When safer or more tolerable treatments are available, danazol usually waits on the bench.

Aromatase Inhibitors

Letrozole and anastrozole are aromatase inhibitors that reduce estrogen production. They are not FDA-approved specifically for endometriosis but may be used off-label by specialists for severe, treatment-resistant pain.

They are often combined with another medication that suppresses ovarian activity. Possible complications include hot flashes, joint pain, ovarian cyst development, and bone loss. These are not casual “let’s try it and see” medicines; they are specialist-level options for carefully selected cases.

What Is the Best Medication If You Want to Get Pregnant?

Hormonal suppression is generally not used to improve natural fertility while a person is actively trying to conceive. Combined birth control, progestins, GnRH agonists, and GnRH antagonists usually prevent ovulation, suppress cycles, or delay attempts at pregnancy.

Research and clinical guidance have not shown routine suppressive hormonal treatment to improve natural pregnancy rates in people with endometriosis-related infertility. Depending on age, ovarian reserve, semen analysis, tubal health, disease severity, and previous treatment, the next step may involve timed conception, surgery, intrauterine insemination, or in vitro fertilization.

Short-term hormonal pretreatment may sometimes be used as part of a fertility-clinic protocol, particularly around assisted reproductive treatment. That is different from taking hormonal suppression as a stand-alone fertility medication and should be directed by a reproductive endocrinologist.

How Doctors Choose the Best Endometriosis Medicine

A good medication decision considers more than a pain score. A clinician may ask about:

• Whether pain occurs only during periods or throughout the month.
• Pain during sex, bowel movements, or urination.
• Heavy bleeding, anemia, fatigue, and missed work or school.
• Current and future pregnancy plans.
• History of migraines, blood clots, liver disease, osteoporosis, depression, or high blood pressure.
• Previous medications, side effects, and treatment duration.
• Whether daily pills, injections, implants, or an IUD are acceptable.
• Insurance coverage and medication cost.

Endometriosis pain may also involve pelvic-floor muscle dysfunction, nerve sensitization, bladder conditions, bowel disorders, adenomyosis, or other causes of chronic pelvic pain. Increasing hormone suppression indefinitely will not solve every one of these problems. Some patients benefit from pelvic-floor physical therapy, pain medicine consultation, gastrointestinal or urologic evaluation, psychological support, or surgery in addition to medication.

When Medication Is Not Enough

A gynecologic evaluation is important when pain remains severe after several medication trials, side effects are unacceptable, imaging shows an endometrioma or deep disease, fertility is affected, or bowel and urinary symptoms suggest organ involvement.

Urgent medical care may be necessary for sudden severe abdominal pain, fainting, fever, persistent vomiting, extremely heavy bleeding, a positive pregnancy test with pelvic pain, or symptoms suggesting bowel or urinary obstruction.

Surgery may be considered when empiric medical treatment fails or when diagnosis, anatomy, fertility, or organ involvement requires direct evaluation. Medication may still be recommended after surgery to reduce the recurrence of symptoms when pregnancy is not immediately desired.

Common Real-World Experiences With Endometriosis Medication

The following are composite examples based on common treatment patterns. They are not testimonials from specific patients and should not be interpreted as medical instructions.

The “My Period Is No Longer Ruining Three Days a Month” Experience

One common experience begins with continuous combined birth control. During the first month or two, spotting may appear at inconvenient timesas though the uterus has discovered push notifications. Mild nausea or breast tenderness may also occur. After several cycles, however, periods may become lighter, less frequent, or absent. A person who previously missed work every month may find that cramps become manageable with occasional pain medication.

The important lesson is that hormonal treatment may need time. Unless side effects are severe, clinicians often evaluate results over several months rather than declaring failure after one imperfect week.

The “Estrogen Was Not My Friend” Experience

Another person may try a combined pill and develop headaches, nausea, or worsening migraines. Their clinician switches them to a progestin-only pill. Bleeding becomes unpredictable at first, but pelvic pain gradually improves. The trade-off is fewer severe pain days in exchange for occasional spotting.

Someone who struggles to remember a daily pill may prefer a hormonal IUD or implant. Another person may dislike the idea of an inserted device and choose oral treatment. Both choices can be reasonable. The best plan is not the one that looks most impressive in a medical chart; it is the one that is safe, effective, and realistic enough to continue.

The “First-Line Treatment Helped, but Not Enough” Experience

A patient may receive partial relief from a progestin but continue to experience nonmenstrual pelvic pain and painful sex. After reviewing bone health, mood history, contraception, and pregnancy plans, a specialist recommends a GnRH antagonist.

Pain may improve noticeably, but hot flashes or sleep disruption can appear. The patient and clinician then weigh symptom relief against side effects, treatment limits, and quality of life. This is where follow-up matters. Specialty medication should not disappear into the medicine cabinet while everyone hopes for the best.

The “Medication Was Only One Piece” Experience

Some patients suppress their periods successfully yet still experience pelvic pressure, muscle spasms, or pain during penetration. Further evaluation may reveal pelvic-floor muscle dysfunction or pain sensitization. Hormonal medication is continued because it controls cyclical symptoms, while pelvic-floor physical therapy and other pain-management strategies address the remaining discomfort.

This experience can be frustrating because it feels as though the medication “did not work.” In reality, it may have treated one major pain generator while another required different care.

The “Pregnancy Plans Changed Everything” Experience

A person may feel well on continuous hormonal contraception for several years and then decide to try for pregnancy. Once treatment stops, symptoms can return. Rather than repeatedly restarting suppression, the patient meets with a fertility specialist to review age, ovarian reserve, fallopian tubes, partner testing, imaging, and previous surgery.

The next treatment is selected around the goal of conception rather than menstrual suppression. This illustrates why the “best” medication can change even for the same person. Endometriosis treatment is not a permanent ranking of drugs; it is a strategy that evolves with health, symptoms, priorities, and life plans.

Conclusion

For most people with endometriosis who are not trying to become pregnant, continuous combined hormonal contraception or a progestin-only medication is the most common starting point. NSAIDs may provide additional pain relief. When first-line therapy is ineffective, GnRH antagonists such as elagolix or relugolix combination therapy, or a GnRH agonist such as leuprolide with add-back therapy, may provide stronger symptom control.

No medication is automatically best for every patient. A useful treatment should improve daily function without creating risks or side effects that outweigh its benefits. Pregnancy goals, bone health, migraine history, clotting risk, mood symptoms, cost, convenience, and personal preference all belong in the decision.

Note: This article provides general educational information and is not a diagnosis or personalized treatment plan. Do not start, stop, or combine prescription medication without consulting a qualified healthcare professional. People with severe pain, heavy bleeding, pregnancy concerns, or new bowel or urinary symptoms should seek medical evaluation.